InterDigital vs Medical Properties Trust
IDCC and MPT side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IDCC and MPT compare
InterDigital is the larger company, worth 7.4 times as much as Medical Properties Trust ($7.6B against $1.0B).
Medical Properties Trust grew revenue faster over the last twelve months (10.6% versus −12.0% for InterDigital).
InterDigital keeps more of each dollar of sales as profit, with a net margin of 38.5% compared with −3.0% at Medical Properties Trust.
Both pay dividends: InterDigital yields 0.96% and Medical Properties Trust 21.1%.
InterDigital scores higher on the StockData Score (18 against 9 for Medical Properties Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IDCC | MPT |
|---|---|---|
| Size and price | ||
| Market cap | $7.6B | $1.0B |
| Share price | $295.41 | $1.71 |
| Change, 1 year | −20.5% | −66.3% |
| Change, 5 years | 311% | −92.1% |
| Beta (5Y) | 0.90 | 1.22 |
| Employees | 460 | 121 |
| StockData Score | ||
| Total score | 18 (better) | 9 |
| Valuation score | 0 | 4 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 6 (better) | 1 |
| Health score | 6 (better) | 0 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 32.5× | – |
| P/S | 9.3× | 1.0× (better) |
| P/B | 6.1× | 0.2× (better) |
| EV/EBITDA | 15.2× | 0.8× (better) |
| P/FCF | 24.7× | – |
| PEG | 0.57 | – |
| FCF yield | 4.1% | – |
| Fair value | $191.90 | $7.93 |
| Margin of safety | −53.9% | 78.4% (better) |
| Growth | ||
| Revenue growth (TTM) | −12.0% | 10.6% (better) |
| Revenue growth, 5Y average | 18.4% (better) | −4.9% |
| Net income growth (TTM) | −36.6% | – |
| EPS growth (TTM) | −38.7% | – |
| EPS growth, 5Y average | 52.3% | – |
| Profitability | ||
| Operating margin | 45.1% | – |
| Net margin | 38.5% (better) | −3.0% |
| FCF margin | 37.8% | – |
| Return on equity | 26.8% (better) | −0.65% |
| Return on invested capital | 83.8% | – |
| Financial health | ||
| Debt / equity | 0.25 | – |
| Net debt / EBITDA | −1.82 | – |
| Interest coverage | 9.9× | – |
| Current ratio | 1.90 | – |
| Altman Z-score | 7.82 (better) | −0.27 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.96% | 21.1% (better) |
| Payout ratio | 22.9% | – |
| Years of dividend growth | 3 (better) | 0 |
| Dividend growth, 5Y average | 13.2% (better) | −21.4% |
| Buyback yield | 1.1% | – |
| Shareholder yield | 2.1% | 21.1% (better) |
| Ownership | ||
| Held by institutions | 106% | 61.1% |
| Held by insiders | 2.1% | 2.2% |
| Insider net buying, 12 months | −$26.2M | −$455 (better) |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 10.6% | 25.5% |
Go deeper
- IDCC stock overview
- IDCC income statement
- IDCC valuation and score
- MPT stock overview
- MPT income statement
- MPT valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.